NCT07378761 2026-01-30
CHILURSO
University Hospital, Montpellier
Phase 2 Not yet recruiting
Clinical Trials
6 trialsNCT06842472 2025-02-24
PD-L1 Inhibitor + RT ± Ursodeoxycholic Acid in Recurrent/Metastatic HER2-Neg Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
NCT04810156 2022-12-14
I-HEP
Herlev Hospital
Phase 2 Unknown
NCT01097304 2017-12-19
Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia
National Cancer Institute (NCI)
Phase 2 Completed
NCT01149304 2017-11-20
ELDORADO
University of Magdeburg
Phase 2 Completed
NCT00062023 2012-07-30
Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated